Case report: A mesenchymal chondrosarcoma with alternative HEY1::NCOA2 fusions in the sella turcica

Pathol Oncol Res. 2024 Aug 6:30:1611730. doi: 10.3389/pore.2024.1611730. eCollection 2024.

Abstract

Introduction: Mesenchymal chondrosarcoma (MCS) is a rare subtype of chondrosarcoma that occurs at widespread anatomical locations, such as bone, soft tissue, and intracranial sites. The central nervous system (CNS) is one of the most common origins of extraosseous MCS. However, alternative HEY1::NCOA2 fusions have not been reported in this tumor.

Case report: We report a case of intracranial MCS with HEY1::NCOA2 rearrangement. A 52-year-old woman presented with a 15-mm calcified mass around the sella turcica. She initially underwent transsphenoidal surgery for tumor resection and then additional resections for five local recurrences over 5 years. Histologically, the tumor was composed of small round to spindle-shaped cells admixed with well-differentiated hyaline cartilaginous islands. A hemangiopericytoma-like vascular pattern and small sinusoid-like vessels were also observed. RNA sequencing using RNA extracted from formalin-fixed paraffin-embedded samples from the last operation revealed two alternative variants of the HEY1::NCOA2 fusion: HEY1(ex4)::NCOA2 (ex13) and HEY1(ex4)::NCOA2(ex14). Both variants were confirmed as in-frame fusions using reverse transcription-polymerase chain reaction.

Discussion: Cartilaginous components were often not apparent during the recurrences. In addition to the non-typical pathological finding, the correct diagnosis was hampered by the poor RNA quality of the surgical specimens and non-specific STAT6 nuclear staining.

Conclusion: This is the first reported case of intracranial MCS with an alternative HEY1::NCOA2 fusion.

Keywords: CNS sarcoma; HEY1::NCOA2; intracranial mesenchymal chondrosarcoma; mesenchymal chondrosarcoma; sella turcica.

Publication types

  • Case Reports

MeSH terms

  • Basic Helix-Loop-Helix Transcription Factors* / genetics
  • Cell Cycle Proteins* / genetics
  • Chondrosarcoma, Mesenchymal* / genetics
  • Chondrosarcoma, Mesenchymal* / pathology
  • Chondrosarcoma, Mesenchymal* / surgery
  • Female
  • Humans
  • Middle Aged
  • Nuclear Receptor Coactivator 2* / genetics
  • Sella Turcica* / pathology

Substances

  • HEY1 protein, human
  • Basic Helix-Loop-Helix Transcription Factors
  • NCOA2 protein, human
  • Nuclear Receptor Coactivator 2
  • Cell Cycle Proteins

Grants and funding

The authors declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Number #20K07415 to TS).